Cancer protection is available with lump sum benefits. Go to ProtectorsLife.com for more information.
Expected Numbers of New Cancer Cases
Table 1 presents the estimated numbers of new cases of invasive cancer in the United States in 2019 by sex and cancer type. In total, there will be approximately 1,762,450 cancer cases diagnosed, which is the equivalent of more than 4,800 new cases each day. In addition, there will be approximately 62,930 new cases of female breast carcinoma in situ and 95,830 new cases of melanoma in situ of the skin. The estimated numbers of new cases by state are shown in Table 2.
|ESTIMATED NEW CASES||ESTIMATED DEATHS|
|BOTH SEXES||MALE||FEMALE||BOTH SEXES||MALE||FEMALE|
|Oral cavity & pharynx||53,000||38,140||14,860||10,860||7,970||2,890|
|Other oral cavity||3,760||2,710||1,050||1,650||1,290||360|
|Anus, anal canal, & anorectum||8,300||2,770||5,530||1,280||520||760|
|Liver & intrahepatic bile duct||42,030||29,480||12,550||31,780||21,600||10,180|
|Gallbladder & other biliary||12,360||5,810||6,550||3,960||1,610||2,350|
|Other digestive organs||7,220||2,990||4,230||2,860||1,230||1,630|
|Lung & bronchus||228,150||116,440||111,710||142,670||76,650||66,020|
|Other respiratory organs||5,880||4,070||1,810||1,080||720||360|
|Bones & joints||3,500||2,030||1,470||1,660||960||700|
|Soft tissue (including heart)||12,750||7,240||5,510||5,270||2,840||2,430|
|Skin (excluding basal & squamous)||104,350||62,320||42,030||11,650||8,030||3,620|
|Melanoma of the skin||96,480||57,220||39,260||7,230||4,740||2,490|
|Other nonepithelial skin||7,870||5,100||2,770||4,420||3,290||1,130|
|Vagina & other genital, female||5,350||5,350||1,430||1,430|
|Penis & other genital, male||2,080||2,080||410||410|
|Kidney & renal pelvis||73,820||44,120||29,700||14,770||9,820||4,950|
|Ureter & other urinary organs||3,930||2,630||1,300||980||600||380|
|Eye & orbit||3,360||1,860||1,500||370||200||170|
|Brain & other nervous system||23,820||13,410||10,410||17,760||9,910||7,850|
|Acute lymphocytic leukemia||5,930||3,280||2,650||1,500||850||650|
|Chronic lymphocytic leukemia||20,720||12,880||7,840||3,930||2,220||1,710|
|Acute myeloid leukemia||21,450||11,650||9,800||10,920||6,290||4,630|
|Chronic myeloid leukemia||8,990||5,250||3,740||1,140||660||480|
|Other leukemia ‡||4,690||2,860||1,830||5,350||3,130||2,220|
|Other & unspecified primary sites ‡||31,480||16,750||14,730||45,140||24,240||20,900|
- * Rounded to the nearest 10; cases exclude basal cell and squamous cell skin cancers and in situ carcinoma except urinary bladder. Approximately 62,930 cases of carcinoma in situ of the female breast and 95,830 cases of melanoma in situ will be newly diagnosed in 2019.
- † Deaths for colon and rectal cancers are combined because a large number of deaths from rectal cancer are misclassified as colon.
- ‡ More deaths than cases may reflect a lack of specificity in recording the underlying cause of death on death certificates and/or an undercount in the case estimate.
- Note: These are model‐based estimates that should be interpreted with caution and not compared with those for previous years.
Figure 1 depicts the most common cancers expected to be diagnosed in men and women in 2019. Prostate, lung and bronchus (referred to as lung hereafter), and colorectal cancers (CRCs) account for 42% of all cases in men, with prostate cancer alone accounting for nearly 1 in 5 new diagnoses. For women, the 3 most common cancers are breast, lung, and colorectum, which collectively represent one‐half of all new diagnoses; breast cancer alone accounts for 30% of all new cancer diagnoses in women.
The lifetime probability of being diagnosed with invasive cancer is slightly higher for men (39.3%) than for women (37.7%) (Table 3). The reasons for the excess risk in men are not fully understood, but partly reflect differences in environmental exposures, endogenous hormones, and probably complex interactions between these influences. Recent research suggests that sex differences in immune function and response may also play a role.25 Adult height, which is determined by genetics and childhood nutrition, is positively associated with cancer incidence and mortality in both men and women,26 and has been estimated to account for one‐third of the sex disparity.27
Cancer Protection is here. Go to ProtectorsLife.com for more information